Tickerlog
NASDAQ
$7.46
-32.560
-9.312
Updated Friday 24th of December 2021 09:35:13 PM

Acumen Pharmaceuticals Inc. Common Stock

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer’s and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
ROE -32.560
EPS -9.312
Marketcap$301.9M
Health Care
Biotechnology: Pharmaceutical Preparations

Top gainers today
Top losers today